Thomas (Tom) Braiden is a partner in the Corporate Practice Group. He advises on a wide range of corporate matters in a number of different industries.

Tom has extensive experience advising public and private companies (as well as family offices and other private investors) on IPOs and secondary fundraisings (both AIM and Official List), mergers and acquisitions, joint ventures, venture capital, commercial contracts, corporate governance issues and other general corporate advice.

Prior to joining Brown Rudnick, Tom was an associate at Slaughter and May.


Represented Arix Bioscience plc, a global healthcare and life science company that sources, finances and develops both start-up and later stage companies across the healthcare and life science sectors, on (i) its initial public offering and admission to trading on the standard segment of the Main Market of the London Stock Exchange, which Arix raised total gross proceeds of £100m in its oversubscribed initial public offering; and (ii) on its subsequent £100m secondary fundraising.

Represented N+1 Singer on the admission of the entire issued share capital of Renalytix AI plc to trading on AIM, which raised approximately £25m through a placing, US subscription and restricted offer to shareholders of EKF Diagnostics Holdings plc. 

Represented the shareholders of Parkwalk Advisors Ltd, the U.K.’s leading university spin-out focused EIS fund manager, on the sale of Parkwalk to IP Group plc.

Advising family offices and other private investors on structuring and executing a broad range of transactions around the world including M&A deals, joint venture transactions and other bespoke investments.

Representing both investors and investee companies in connection with numerous venture capital and growth equity transactions.

Representing Boon Rawd Trading International on the execution of its new distribution partnership with Shepherd Neame, under which Shepherd Neame has become the sole distributor of Singha beer in the U.K.


BPP University Law School – LPC, Distinction, 2009
Oxford Brookes University – Graduate Diploma in Law, Merit, 2008
Oxford University – Philosophy and Theology, 2007

Bar Admissions

England and Wales
Co-author "The impact of COVID-19 on domestic and cross-border M&A", Financier Worldwide Magazine (June 2020)
Awards and Honors
Recognized by The Legal 500 UK as a Recommended Lawyer for Venture Capital (2021). The team is described as "extremely knowledgeable and capable in this area."